vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.69M | -18.46M | -18.31M | -20.18M | -20.62M |
| Total Depreciation and Amortization | 76.00K | 89.00K | 90.00K | 90.00K | 90.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.20M | -1.50M | -2.24M | -25.00K | -1.29M |
| Change in Net Operating Assets | -3.85M | -5.44M | -2.94M | -1.70M | 569.00K |
| Cash from Operations | -23.66M | -25.31M | -23.40M | -21.81M | -21.25M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 4.40M | 4.40M | 4.40M |
| Cash from Investing | -- | -- | 4.40M | 4.40M | 4.40M |
| Total Debt Issued | -- | -- | 0.00 | 566.00K | 566.00K |
| Total Debt Repaid | 0.00 | -191.00K | -473.00K | -566.00K | -566.00K |
| Issuance of Common Stock | 2.46M | 52.80M | 52.80M | 50.34M | 50.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.46M | 52.61M | 52.33M | 50.34M | 50.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.20M | 27.30M | 33.33M | 32.93M | 33.49M |